ModelEdge
Arca Biopharma Inc.
ABIO
Filing type
10-K
Filing date
Mar 5, 2025
Updated
Mar 6, 2025 ยท 2:02 PM

Filing

10-KFY 2024

Exhibits

EX-4.1DESCRIPTION OF SECURITIESEX-4.3FORM OF PRE-FUNDED WARRANT, DATED AUGUST 29, 2024EX-10.17AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN ORUKA THERAPEUTICS, INC. AND PAUL QUINLAN, DATED OCTOBER 1, 2024EX-10.18AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT BY AND BETWEEN ORUKA THERAPEUTICS, INC. AND JOANA GONCALVES, DATED OCTOBER 1, 2024EX-10.19FORM OF INDEMNIFICATION AGREEMENTEX-10.20NON-EMPLOYEE DIRECTORS COMPENSATION PROGRAMEX-10.29IL-17 LICENSE AGREEMENT BY AND BETWEEN PARAGON THERAPEUTICS, INC. AND ORUKA THERAPEUTICS, INC., DATED FEBRUARY 4, 2025EX-10.31IL-23 LICENSE AGREEMENT BY AND BETWEEN PARAGON THERAPEUTICS, INC. AND ORUKA THERAPEUTICS, INC., DATED DECEMBER 17, 2024EX-10.32CELL LINE LICENSE AGREEMENT BY AND BETWEEN WUXI BIOLOGICS IRELAND LIMITED AND ORUKA THERAPEUTICS, INC., DATED MARCH 4, 2024EX-10.33AMENDMENT NO. 1 TO THE CELL LINE LICENSE AGREEMENT BY AND BETWEEN WUXI BIOLOGICS IRELAND LIMITED AND ORUKA THERAPEUTICS, INC., DATED NOVEMBER 20, 2024EX-19.1INSIDER TRADING POLICYEX-21.1LIST OF SUBSIDIARIES OF THE REGISTRANTEX-23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMEX-31.1CERTIFICATIONEX-31.2CERTIFICATIONEX-32.1CERTIFICATIONEX-97.1INCENTIVE COMPENSATION CLAWBACK POLICYGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic